UPDATE: BMO Capital Upgrades Amedisys (AMED) to Outperform
Tweet Send to a Friend
(Updated - February 25, 2022 5:03 AM EST)
BMO Capital analyst Matt Borsch upgraded Amedisys (NASDAQ: AMED) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Matt Borsch upgraded Amedisys (NASDAQ: AMED) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
